產(chǎn)品名稱(chēng) |
173-1C11 |
商品貨號(hào) |
B163603 |
Organism |
Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
Cell Type |
hybridoma: B lymphocyte |
Product Format |
frozen |
Morphology |
lymphoblast |
Culture Properties |
suspension |
Biosafety Level |
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
Storage Conditions |
liquid nitrogen vapor phase |
Derivation |
Spleen cells were fused with Sp2/0 myeloma cells. |
Genes Expressed |
immunoglobulin; monoclonal antibody; against a synthetic v-erb B oncogene peptide |
Cellular Products |
immunoglobulin; monoclonal antibody; against a synthetic v-erb B oncogene peptide |
Comments |
Spleen cells were fused with Sp2/0 myeloma cells. |
Complete Growth Medium |
The base medium for this cell line is ATCC-formulated Dulbecco's Modified Eagle's Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
|
Subculturing |
Protocol: Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 1 to 2 X 10 exp5 viable cells/ml. Maintain cell density between 1 X 10 exp5 and 1 X 10 exp6 viable cells/ml. Medium Renewal: Add fresh medium every 2 to 3 days (depending on cell density) |
Cryopreservation |
Freeze medium: Complete growth medium 95%; DMSO, 5% Storage temperature: liquid nitrogen vapor phase |
Culture Conditions |
Temperature: 37.0°C |
Isotype |
IgG1 kappa |
Name of Depositor |
National Cancer Institute |
Deposited As |
mouse (B cell); mouse (myeloma) |